Baker Bros. Advisors LP 13D and 13G filings for Achilles Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:23 pm Sale |
2024-09-30 | 13G | Achilles Therapeutics plc ACHL |
Baker Bros. Advisors LP | 0 0.000% |
-3,311,567 (Position Closed) |
Filing |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Achilles Therapeutics plc ACHL |
Baker Bros. Advisors LP | 3,311,567 8.100% |
-896,166 (-21.30%) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Achilles Therapeutics plc ACHL |
Baker Bros. Advisors LP | 4,207,733 9.900% |
168,253 (+4.17%) |
Filing |
| 2022-02-14 4:12 pm Purchase |
2021-12-31 | 13G | Achilles Therapeutics plc ACHL |
Baker Bros. Advisors LP | 4,039,480 9.990% |
4,039,480 (New Position) |
Filing |